Submitted by Anonymous (not verified) on 13 September 2023 - 10:58
Opinion/decision on a Paediatric investigation plan (PIP): Humanized monoclonal antibody of IgG1 subtype targeting NRP1, decision type: , therapeutic area: , PIP number: P/0283/2022
Source: